Scottish Medicines Consortium

SMC accepts three new medicines for use by NHSScotland

The Scottish Medicines Consortium (SMC) which advises on newly licensed medicines for use by NHSScotland has today (Monday 8 November) published advice acceptin... Read More...

Single tablet cholesterol-lowering combination accepted for NHS use in Scotland

• High blood cholesterol increases the risk of cardiovascular disease (CVD), which was the leading cause of death in Scotland in 2020, equating to nearly 50 pe... Read More...

SMC issues positive advice for treatment with Ofev® (nintedanib) for patients with chronic fibrosing interstitial lung diseases with a progressive phenotype (PF-ILD)

The Scottish Medicines Consortium (SMC) has today announced that Ofev® (nintedanib) has been accepted for use by NHSScotland for the treatment of adult patients... Read More...

Healthcare Professional ONLY

This website is intended for Healthcare professionals only

Are you a qualified pharmacist or health professional?
By continuing to access this site, you are consenting to viewing promotional product information provided by our pharmaceutical company sponsors